Until the COVID-19 pandemic few outside of academic or diagnostic labs knew what quantitative reverse-transcription PCR (PR-qPCR) was, but the need for tens of millions of reliable SARS-CoV-2 diagnostic tests has driven rapid and widespread development of RT-qPCR assays. It has also fueled research into evolving the sensitivity, speed and versatility of RT-qPCR.
- To overcome the limitations of PCR testing
- RT-qPCR will impact diagnostics both in lab and at point of care
- RT-qPCR is driving new methods and applications